3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia, Myeloid, Acute
5
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell
3
Triple Negative Breast Neoplasms
2
Lymphoma
2
Glioblastoma
2
Burkitt Lymphoma
2
Sarcoma, Synovial
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neuroblastoma
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Liposarcoma, Myxoid
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Diseases
1
Ganglioneuroblastoma
1
Fallopian Tube Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Astrocytoma
1
Interventions
X-Rays
7
Phantoms, Imaging
7
Specimen Handling
6
Magnetic Resonance Spectroscopy
6
Nuclear Medicine Department, Hospital
5
Biopsy
5
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
fludarabine
2
erdafitinib
2
ensartinib
2
Vincristine
2
Temozolomide
2
LY3023414
2
Fluorouracil
2
Doxorubicin
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
talazoparib
1
sodium thiosulfate
1
pembrolizumab
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hepatoblastoma
×
Leukapheresis
×
90 days
×
Clear all
No trials found.